Exoskeleton and Spinal Cord Stimulation for SCI

Launched by KESSLER FOUNDATION · Mar 23, 2017

Keywords

ClinConnect Summary

This clinical trial is exploring how a combination of two treatments can help people with spinal cord injuries (SCI) regain their ability to walk. The study is looking at the effects of using a special device called an exoskeleton, which helps support movement, along with a type of stimulation applied to the lower back area. Researchers want to find out if this combined approach is more effective than using the exoskeleton alone.

To participate, individuals must be between 21 and 58 years old, have had a spinal cord injury for more than six years, and be unable to walk independently, relying on a wheelchair for mobility. They should also have a certain level of muscle control in their legs and meet specific height and bone density requirements. Those who have had broken bones or certain bone diseases are not eligible. Participants can expect to take part in walking exercises while using the exoskeleton, and their progress will be monitored throughout the study. This research aims to improve recovery options and enhance mobility for those with similar injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• In order to be eligible to participate in this study a participant must:
• • be a non-walker with an SCI greater than 6 years post injury;
• • have a lower extremity motor score greater or equal to 16 as measured by the International Standards for Neurological Classification of SCI exam;
• • be between the ages of 21-58 years old;
• • have a spinal cord injury at a neurological level of injury as determined by study staff between C6-T-10;
• • be wheelchair reliant 100% of the time;
• • have knee bone mineral density great than .5755gm/cm2 as determined by study staff;
• • have a height between 62 inches to 74 inches.
• Exclusion Criteria:
• • have a history of broken or fractured bones.
• • have a history of bone trauma or bone disease.